IDL Biotech AB (publ) is a public company listed on the Swedish equities market place Aktietorget. In total, approximately 1.500 shareholders are involved, the main holder being the Labex Group.
In accordance with all regulations, IDL issues quarterly reports to the market and distributes the annual report to all shareholders. All this information is in Swedish.
The share holder's annual meeting is usually held in Stockholm, and is announced accordingly.
Find the latest news on our IR-page here
2018-02-22 IDL Biotech fourth quarter report and Year-end report 2017